BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8254051)

  • 1. Bence Jones proteins bind to a common peptide segment of Tamm-Horsfall glycoprotein to promote heterotypic aggregation.
    Huang ZQ; Kirk KA; Connelly KG; Sanders PW
    J Clin Invest; 1993 Dec; 92(6):2975-83. PubMed ID: 8254051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical interaction between Tamm-Horsfall glycoprotein and Ig light chains in the pathogenesis of cast nephropathy.
    Huang ZQ; Sanders PW
    Lab Invest; 1995 Dec; 73(6):810-7. PubMed ID: 8558842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of a single binding site for immunoglobulin light chains on human Tamm-Horsfall glycoprotein.
    Huang ZQ; Sanders PW
    J Clin Invest; 1997 Feb; 99(4):732-6. PubMed ID: 9045877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the binding domain of immunoglobulin light chains for Tamm-Horsfall protein.
    Ying WZ; Sanders PW
    Am J Pathol; 2001 May; 158(5):1859-66. PubMed ID: 11337384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins.
    Sanders PW; Booker BB; Bishop JB; Cheung HC
    J Clin Invest; 1990 Feb; 85(2):570-6. PubMed ID: 2298921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathobiology of cast nephropathy from human Bence Jones proteins.
    Sanders PW; Booker BB
    J Clin Invest; 1992 Feb; 89(2):630-9. PubMed ID: 1737851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and treatment of myeloma kidney.
    Sanders PW
    J Lab Clin Med; 1994 Oct; 124(4):484-8. PubMed ID: 7930873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of carbohydrate in the interaction of Tamm-Horsfall protein with complement 1q and inhibition of classical complement activation.
    Rhodes DC
    Immunol Cell Biol; 2006 Aug; 84(4):357-65. PubMed ID: 16594900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetramer Bence Jones protein in the immunoproliferative diseases. Angioimmunoblastic lymphadenopathy, primary amyloidosis, and multiple myeloma.
    Kosaka M; Iishi Y; Okagawa K; Saito S; Sugihara J; Muto Y
    Am J Clin Pathol; 1989 Jun; 91(6):639-46. PubMed ID: 2499179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenicity of catalytic antibodies: catalytic activity of Bence Jones proteins from myeloma patients with renal impairment can elicit cytotoxic effects.
    Matsuura K; Ohara K; Munakata H; Hifumi E; Uda T
    Biol Chem; 2006 May; 387(5):543-8. PubMed ID: 16740125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragment.
    Paul S; Li L; Kalaga R; Wilkins-Stevens P; Stevens FJ; Solomon A
    J Biol Chem; 1995 Jun; 270(25):15257-61. PubMed ID: 7797511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of multiple myeloma with alternating paraprotein; non-secretory myeloma (IgG-kappa) converted to nonproducing myeloma, and finally to secretory myeloma (BJ-lambda) (author's transl)].
    Fujii H; Kanoh T
    Nihon Naika Gakkai Zasshi; 1981 Nov; 70(11):1553-61. PubMed ID: 6801164
    [No Abstract]   [Full Text] [Related]  

  • 13. Double Bence Jones proteinuria.
    Kanoh T; Yago K
    Arch Pathol Lab Med; 1990 Sep; 114(9):991-4. PubMed ID: 2117911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloma kidney cast nephropathy in a rat model of multiple myeloma.
    Smolens P; Venkatachalam M; Stein JH
    Kidney Int; 1983 Aug; 24(2):192-204. PubMed ID: 6415338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic stability and sequence/structure studies of urine-derived Bence-Jones proteins from multiple myeloma and light chain amyloidosis patients.
    Blancas-Mejía LM; Martin EB; Williams A; Wall JS; Ramirez-Alvarado M
    Biophys Chem; 2017 Nov; 230():89-98. PubMed ID: 28916410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring Bence Jones proteins with antibodies against bound immunoglobulin light-chains: how reliable are the results?
    Boege F
    Eur J Clin Chem Clin Biochem; 1993 Jun; 31(6):403-5. PubMed ID: 8369369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of Tamm-Horsfall protein to complement 1q measured by ELISA and resonant mirror biosensor techniques under various ionic-strength conditions.
    Rhodes DC
    Immunol Cell Biol; 2000 Oct; 78(5):474-82. PubMed ID: 11050529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of human Tamm-Horsfall glycoprotein with Bordetella pertussis toxin.
    Menozzi FD; Debrie AS; Tissier JP; Locht C; Pethe K; Raze D
    Microbiology (Reading); 2002 Apr; 148(Pt 4):1193-1201. PubMed ID: 11932463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabbit urinary tamm-horsfall glycoprotein. Chemical composition and tentative carbohydrate structure.
    Fabricius T; Scott DM; Kinne RK
    Biol Chem Hoppe Seyler; 1989 Feb; 370(2):151-8. PubMed ID: 2706085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of low molecular weight serum proteins: physicochemical interactions between myoglobin, hemoglobin, bence-jones proteins and tamm-horsfall mucoprotein.
    Clyne DH; Kant KS; Pesce AJ; Pollak VE
    Curr Probl Clin Biochem; 1979; (9):299-308. PubMed ID: 446077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.